342 related articles for article (PubMed ID: 16215196)
1. Substance abuse relapse in a ten-year prospective follow-up of clients with mental and substance use disorders.
Xie H; McHugo GJ; Fox MB; Drake RE
Psychiatr Serv; 2005 Oct; 56(10):1282-7. PubMed ID: 16215196
[TBL] [Abstract][Full Text] [Related]
2. Substance abuse relapse and factors associated with relapse in an inner-city sample of patients with dual diagnoses.
Rollins AL; O'Neill SJ; Davis KE; Devitt TS
Psychiatr Serv; 2005 Oct; 56(10):1274-81. PubMed ID: 16215195
[TBL] [Abstract][Full Text] [Related]
3. Future directions in preventing relapse to substance abuse among clients with severe mental illnesses.
Drake RE; Wallach MA; McGovern MP
Psychiatr Serv; 2005 Oct; 56(10):1297-302. PubMed ID: 16215199
[TBL] [Abstract][Full Text] [Related]
4. Postdischarge cannabis use and its relationship to cocaine, alcohol, and heroin use: a prospective study.
Aharonovich E; Liu X; Samet S; Nunes E; Waxman R; Hasin D
Am J Psychiatry; 2005 Aug; 162(8):1507-14. PubMed ID: 16055773
[TBL] [Abstract][Full Text] [Related]
5. Remission of substance use disorder among psychiatric inpatients with mental illness.
Dixon L; McNary S; Lehman AF
Am J Psychiatry; 1998 Feb; 155(2):239-43. PubMed ID: 9464204
[TBL] [Abstract][Full Text] [Related]
6. Ten-year recovery outcomes for clients with co-occurring schizophrenia and substance use disorders.
Drake RE; McHugo GJ; Xie H; Fox M; Packard J; Helmstetter B
Schizophr Bull; 2006 Jul; 32(3):464-73. PubMed ID: 16525088
[TBL] [Abstract][Full Text] [Related]
7. Comparisons of patients with comorbid psychiatric and substance use disorders: implications for treatment and service delivery.
Havassy BE; Alvidrez J; Owen KK
Am J Psychiatry; 2004 Jan; 161(1):139-45. PubMed ID: 14702262
[TBL] [Abstract][Full Text] [Related]
8. Subtypes of clients with serious mental illness and co-occurring disorders: latent-class trajectory analysis.
Xie H; McHugo GJ; Drake RE
Psychiatr Serv; 2009 Jun; 60(6):804-11. PubMed ID: 19487351
[TBL] [Abstract][Full Text] [Related]
9. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
[TBL] [Abstract][Full Text] [Related]
10. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
Brunette MF; Noordsy DL; Xie H; Drake RE
Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
[TBL] [Abstract][Full Text] [Related]
11. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
[TBL] [Abstract][Full Text] [Related]
12. Effect of managed care on access to mental health services among Medicaid enrollees receiving substance treatment.
Bigelow DA; McFarland BH; McCamant LE; Deck DD; Gabriel RM
Psychiatr Serv; 2004 Jul; 55(7):775-9. PubMed ID: 15232016
[TBL] [Abstract][Full Text] [Related]
13. A dual diagnosis demonstration project: treatment outcomes and cost analysis.
Judd PH; Thomas N; Schwartz T; Outcalt A; Hough R
J Psychoactive Drugs; 2003 May; 35 Suppl 1():181-92. PubMed ID: 12825761
[TBL] [Abstract][Full Text] [Related]
14. Gender differences in treatment retention among individuals with co-occurring substance abuse and mental health disorders.
Choi S; Adams SM; Morse SA; MacMaster S
Subst Use Misuse; 2015 Apr; 50(5):653-63. PubMed ID: 25587672
[TBL] [Abstract][Full Text] [Related]
15. Integrated versus parallel treatment of co-occurring psychiatric and substance use disorders.
Mangrum LF; Spence RT; Lopez M
J Subst Abuse Treat; 2006 Jan; 30(1):79-84. PubMed ID: 16377455
[TBL] [Abstract][Full Text] [Related]
16. Impact of comorbid psychiatric disorders on the outcome of substance abusers: a six year prospective follow-up in two Norwegian counties.
Landheim AS; Bakken K; Vaglum P
BMC Psychiatry; 2006 Oct; 6():44. PubMed ID: 17054775
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal Course of Clients With Co-occurring Schizophrenia-Spectrum and Substance Use Disorders in Urban Mental Health Centers: A 7-Year Prospective Study.
Drake RE; Luciano AE; Mueser KT; Covell NH; Essock SM; Xie H; McHugo GJ
Schizophr Bull; 2016 Jan; 42(1):202-11. PubMed ID: 26294706
[TBL] [Abstract][Full Text] [Related]
18. A national survey of care for persons with co-occurring mental and substance use disorders.
Watkins KE; Burnam A; Kung FY; Paddock S
Psychiatr Serv; 2001 Aug; 52(8):1062-8. PubMed ID: 11474052
[TBL] [Abstract][Full Text] [Related]
19. Behavioral interventions for dual-diagnosis patients.
Goldsmith RJ; Garlapati V
Psychiatr Clin North Am; 2004 Dec; 27(4):709-25. PubMed ID: 15550289
[TBL] [Abstract][Full Text] [Related]
20. Psychosocial interventions for the long-term management of patients with severe mental illness and co-occurring substance use disorder.
Brunette MF; Mueser KT
J Clin Psychiatry; 2006; 67 Suppl 7():10-7. PubMed ID: 16961419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
